A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
NCT07503808
This study is recruiting at 15 US sites in 9 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a Phase 1a/1b, open-label, multicenter dose escalation and dose expansion clinical study to evaluate the safety, PK, immunogenicity and preliminary efficacy of IDE034 in participants with locally advanced/metastatic solid tumor types that express B7-H3 and PTK7.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Esophageal Squamous Cell Carcinoma
- High Grade Serous Ovarian Cancer
- Head and Neck Squamous Cell Carcinoma
- Colorectal Cancer
- Castration-resistant Prostate Cancer
- Non Small Cell Lung Cancer
- Endometrium Cancer
- Triple Negative Breast Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- IDEAYA Biosciences
- Last updated on ClinicalTrials.gov
- June 18, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 1
- Sarah Cannon Research Institute at HealthONE · Denver, CO
Florida · 1
- Florida Cancer Specialists · Sarasota, FL
Michigan · 1
- Karmanos Cancer Institute · Detroit, MI
New York · 1
- START New York Long Island, LLC · Lake Success, NY
Tennessee · 1
- SCRI Oncology Partners · Nashville, TN
Texas · 7
- NEXT Texas LLC - Austin · Austin, TX
- START Dallas Fort Worth, LLC · Fort Worth, TX
- MD Anderson · Houston, TX
- NEXT Texas LLC - Houston · Houston, TX
- NEXT Texas LLC - Dallas · Irving, TX
- NEXT Texas LLC - San Antonio · San Antonio, TX
- START San Antonio, LLC · San Antonio, TX
Utah · 1
- START Mountain Region, LLC · West Valley City, UT
Virginia · 1
- NEXT Texas LLC - Virginia · Fairfax, VA
Washington · 1
- Medical Oncology Associates · Spokane, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.